Importance: Cognitive abnormalities may emerge during prodromal neuronal a-synuclein disease (NSD), but their domain specificity and longitudinal course are uncertain. Objective: To characterize baseline cognition and longitudinal change in prodromal NSD compared with healthy controls, NSD-negative genetic carriers, and sporadic Parkinson disease (PD). Design: Longitudinal cohort study using Parkinson’s Precision Medicine Initiative (PPMI) data, with first visits from July 2010 through April 2026 and up to 4 years of follow-up.
Cognitive Performance in Prodromal Neuronal α Synuclein Disease
calendar_today
November 6, 2026
person
Anis, S., Zimmerman, E., Sperling, S. A., Alberts, J. L., Weintraub, D., Simuni, T., Siderowf, A., Fernandez, H. H., on behalf of the Parkinson's Precision Medicine Initiative
domain
medrxiv